secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVANOS MEDICAL, INC. (AVNS)
CIK:        0001606498
Form:       8-K
Filed at:   2024-12-03T23:59:59+00:00
Accession:  0001606498-24-000094
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avanos Medical formalizes Interim CFO consulting agreement with Warren Machan through May 2025
--------------------------------------------------------------------------------

- Warren Machan appointed Interim CFO effective Oct 28, 2024; consulting agreement formalized Dec 2, 2024.
- Consulting term runs through May 31, 2025; either party may terminate with 30 days' notice.
- Monthly fees: $45,000 through Feb 2025, then $60,000 for Mar-May 2025; plus two $45,000 cash bonuses.
- Bonuses tied to continued service through Feb 28 and May 31, 2025, and satisfactory performance as determined by CEO.
- Independent contractor arrangement; no equity or employee benefits; non-solicitation for one year after term.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1606498/000160649824000094/0001606498-24-000094-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1606498/000160649824000094/avns-20241202.htm
  HTML page:      https://secwatch.observer/filing/0001606498-24-000094

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer